April 24, 2014, 8:30 AM, *** Room 321 MacNider Hall***
“From the bench to public policy—the odyssey of HPTN 052”
Susan Fiscus, PhD
Professor of Microbiology and Immunology and of Pathology and Laboratory Medicine
May 1, 2014, 8:30 AM, *** Room 321 MacNider Hall***
DPLM Faculty Meeting
May 8, 2014, 8:30 AM, *** Room 321 MacNider Hall***
“Sliding and hopping along DNA: the dynamic distribution of methyl-cytosine binding domain proteins on DNA”
David C. Williams, Jr., MD, PhD
Associate Professor of Pathology and Laboratory Medicine
May 15, 2014, 8:30 AM, *** Room 321 MacNider Hall***
“Dosage during development: from mouse models to pharmacology”
Kathleen M. Caron, PhD
Assistant Dean for Research, School of Medicine, and Professor and Chair of Cell Biology and Physiology
May 22, 2014, 8:30 AM, ***G100 Bondurant***
“Unraveling the acute mechanisms that underlie increased cardiovascular risk to short-term spikes in air pollution”
Aimen Farraj, PhD, DABT
Research Biologist, US Environmental Protection Agency
Research Triangle Park, NC
May 29, 2014, 8:30 AM, ***G100 Bondurant***
“Study of EglN2 and oxygen sensing pathway in breast cancer”
Qing Zhang, PhD
Assistant Professor of Pathology and Laboratory Medicine
Sponsored by The School of Medicine of The University of North Carolina at Chapel Hill
Accreditation Statement: The School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- Credit Statement: The School of Medicine of The University of North Carolina at Chapel Hill designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
- Commercial Support Disclosure: In accordance with the ACCME Essentials and Standards, everyone involved in planning or presenting this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry, and this information will be made available to participants at the start of the activity. In addition, speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
- Learning Objectives for the Participants:
The information presented at this educational activity should improve your ability to:
1. Understand current mechanisms of diseases and/or treatments.
2. Be acquainted with improvements in diagnostic accuracy or classification systems.
3. Appreciate the value of scientific understanding of diseases for improving clinical management of patients.
4. Recognize possible opportunities to collaborate with speakers or other attendees/participants.
5. Discuss advances in pathology, medicine, and related disciplines and where possible, their translation to patient care.
6. Discuss the research and service interests of faculty, housestaff, and other department members at UNC and other institutions.
- Americans with Disabilities Act: The University of North Carolina at Chapel Hill is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, sexual orientation, or veteran’s status. If you require reasonable accommodations for a disability in order to participate fully in this continuing education activity, please contact Brenda Brock at 919-843-5878.